Results per Page:
Glitch to switch: Turning spliceosome mutations into immune targets
From the Bleakley Lab, Translational Science and Therapeutics Division
Experimental, precision strategy targets unique cancer protein found in certain acute myeloid leukemia cases
Lab study shows promise of aiming genetically engineered T-cell therapy at a gene fusion